Epiread | YesPress

Browse all tags

ceo2908 saas2409 ai1721 fintech1451 founder1251 b2b1071 b2b saas882 san francisco822 co-founder814 san-francisco796 y combinator768 startup729 machine learning663 enterprise software623 stanford603 series a590 venture capital576 biotech543 cybersecurity532 healthtech479 new york startup469 enterprise-software445 ai agents442 generative ai436 digital health434 silicon-valley389 agentic ai388 d2c383 silicon valley380 ecommerce378 machine-learning373 startup founder360 california351 entrepreneur350 new york347 venture-capital340 edtech338 climate tech327 newsletter321 mit302 proptech301 robotics292 y-combinator279 san francisco startup278 series b270 enterprise ai269 developer tools264 computer vision254 oncology251 open-source247 series-a243 harvard242 sustainability239 supply chain231 enterprise230 iot229 biotechnology222 compliance222 workflow automation221 telehealth217 founder ceo216 healthcare212 insurtech211 developer-tools210 blockchain209 devops208 medical devices206 series-b206 forbes 30 under 30194 llm192 logistics190 uc berkeley189 author188 deep tech187 clean energy186 generative-ai185 web3184 a16z183 cloud183 drug discovery182 life sciences176 artificial intelligence175 no-code175 manufacturing173 b2c172 payments170 general partner169 healthcare ai169 serial entrepreneur167 seed funding164 open source162 crm161 podcast160 hardware159 unicorn158 digital transformation156 predictive analytics152 automation151 crypto150 infrastructure150

Often tagged with

moonwalk biosciences1 epigenetics1 epigenetic editing1 precision medicine1 genomics1 single-cell methylation1 liquid biopsy1 grail1 illumina1 feng zhang1 biotech founder1 ceo1 cancer early detection1 cellular reprogramming1

Tagged: epiread

1 result

Sort

Founder · Executive · Scientist

Alex Aravanis

Alex Aravanis is the CEO and co-founder of Moonwalk Biosciences, a precision epigenetics company he launched in 2024 with $57 million and Broad Institute scientist Feng Zhang. An engineer-turned-physician with degrees from UC Berkeley and Stanford, he co-founded the cancer early-detection company GRAIL, later returned to Illumina as Chief Technology Officer, and now wants to rewrite the 'software of the genome' without cutting a single strand of DNA.

moonwalk biosciences · epigeneticsRead →